nu6102 has been researched along with pha 848125 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gucký, T; Hendrychová, D; Jorda, R; Kryštof, V; Řezníčková, E; Voller, J | 1 |
| Caldon, EC; Tadesse, S; Tilley, W; Wang, S | 1 |
1 review(s) available for nu6102 and pha 848125
| Article | Year |
|---|---|
Cyclin-Dependent Kinase 2 Inhibitors in Cancer Therapy: An Update.
Topics: Animals; Antineoplastic Agents; Clinical Trials as Topic; Cyclin-Dependent Kinase 2; Drug Design; Humans; Neoplasms; Protein Binding; Protein Conformation; Protein Kinase Inhibitors | 2019 |
1 other study(ies) available for nu6102 and pha 848125
| Article | Year |
|---|---|
How Selective Are Pharmacological Inhibitors of Cell-Cycle-Regulating Cyclin-Dependent Kinases?
Topics: Cell Cycle; Cyclin-Dependent Kinases; HCT116 Cells; Humans; Protein Kinase Inhibitors; Quinolines; Thiazoles | 2018 |